Estrogen Withdrawal-Induced NF-κB Activity and Bcl-3 Expression in Breast Cancer Cells: Roles in Growth and Hormone Independence

REFERENCES

• Ausubel, F. M., R. Brent, R. E Kingston, D. D. Moore, J. G. Seidman, J. Smith, and K. Struhl. 1989. Short protocols in molecular biology, 3rd ed. John Wiley & Sons, New York, N.Y.
   Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87: 13–20.
   PubMed Web of Science ®Google Scholar
• Baichwal, V. R., and P. A. Baeuerle. 1997. Apoptosis: activate NF-κB or die? Curr. Biol. 7: R94–R96.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6: 1899–1923.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNFα-induced death. Science 274: 782–784.
   PubMed Web of Science ®Google Scholar
• Beraud, C., W. J. Henzel, and P. A. Baeuerle. 1999. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc. Natl. Acad. Sci. USA 96: 429–434.
   PubMed Web of Science ®Google Scholar
• Biswas, D. K., S.-C. Dai, A. Cruz, B. Weiser, E. Graner, and A. B. Pardee. 2001. The nuclear factor kappa B (NF-κB): a potential therapeutic target for estrogen receptor negative breast cancers. Proc. Natl. Acad. Sci. USA 98: 10386–10391.
   PubMed Web of Science ®Google Scholar
• Braiser, A. R., M. Lu, T. Hai, Y. Lu, and I. Boldogh. 2001. NF-κB-inducible Bcl-3 expression is an autoregulatory loop controlling nuclear p50/NF-κB1 residence. J. Biol. Chem. 276: 32080–32093.
   PubMedGoogle Scholar
• Brunner, N., V. Boulay, A. Fojo, C. E. Freter, M. E. Lippman, and R. Clarke. 1993. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res. 53: 283–290.
   PubMed Web of Science ®Google Scholar
• Bui, N. T., A. Livolsi, J.-F. Peyron, and J. H. M Prehn. 2001. Activation of nuclear factor κB and bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IκBα. J. Cell Biol. 152: 753–763.
   PubMed Web of Science ®Google Scholar
• Cerillo, G., A. Rees, N. Manchanda, C. Reilly, I. Brogan, A. White, and M. Needham. 1998. The oestrogen receptor regulates NF-κB and AP-1 activity in a cell-specific manner. J. Steroid Biochem. Mol. Biol. 67: 79–88.
   PubMed Web of Science ®Google Scholar
• Chen, F., V. Castronova, and X. Shi. 2001. New insights into the role of nuclear factor-κB in cell growth regulation. Am. J. Pathol. 159: 387–397.
   PubMed Web of Science ®Google Scholar
• Cho, H., P. A. Ng, and B. S. Katzenellenbogen. 1991. Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines. Mol. Endocrinol. 5: 1323–1330.
   PubMedGoogle Scholar
• Clarke, R., N. Brunner, B. S. Katzenellenbogen, E. W. Thompson, M. J. Norman, C. Koppi, S. Paik, M. E. Lippman, and R. B. Dickson. 1989. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc. Natl. Acad. Sci. USA 86: 3649–3653.
   PubMedGoogle Scholar
• Clarke, R., E. W. Thompson, F. Leonessa, M. Lippman, M. McGarvey, T. L. Frandsen, and N. Brunner. 1993. Hormone resistance, invasiveness and metastatic potential in breast cancer. Breast Cancer Res. Treat. 24: 227–239.
   Google Scholar
• Cogswell, P. C., D. C. Guttridge, W. K. Funkhouser, and A. S. Baldwin. 2000. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB/p52 and for Bcl-3. Oncogene 19: 1123–1131.
   PubMed Web of Science ®Google Scholar
• Delfino, F., and W. H. Walker. 1999. Hormonal regulation of the NF-κB signaling pathway. Mol. Cell. Endocrinol. 157: 1–9.
   PubMedGoogle Scholar
• Deveraux, Q. L., S. L. Schendel, and J. C. Reed. 2001. Anti-apoptotic proteins. The bcl-2 and inhibitor of apoptosis protein families. Cardiol. Clin. 19: 57–74.
   PubMedGoogle Scholar
• Finco, T. S., and A. S. Baldwin, Jr. 1993. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor B requires Raf-1. J. Biol. Chem. 268: 17676–17679.
   PubMed Web of Science ®Google Scholar
• Fruehauf, J. P., E. G. Mimnaugh, and B. K. Sinha. 1991. Doxorubicin-induced cross-resistance to tumor necrosis factor (TNF) related to differential TNF processing. J. Immunother. 10: 165–173.
   PubMed Web of Science ®Google Scholar
• Gross, A., J. M. McDonnell, and S. J. Korsmeyer. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13: 1899–1911.
   PubMed Web of Science ®Google Scholar
• Higgins, K. A., J. R. Perez, T. A. Coleman, K. Dorshkind, W. A. McComas, U. M. Sarmiento, C. A. Rosen, and R. Narayanan. 1993. Antisense inhibition of the p65 subunits of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA 90: 9901–9905.
   PubMed Web of Science ®Google Scholar
• Hinz, M., D. Krappmann, A. Eichten, A. Heder, C. Scheidereit, and M. Strauss. 1999. NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19: 2690–2698.
   PubMed Web of Science ®Google Scholar
• Hiroasu, N., M. Shindo, S. Sakon, S. Nishinaka, M. Mihara, H. Yagita, and K. Okumura. 1998. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA 95: 3537–3542.
   PubMedGoogle Scholar
• Horwitz, K. B. 1993. Mechanisms of hormone resistance in breast cancer. Breast Cancer Res. Treat. 26: 119–130.
   Google Scholar
• Huxford, T., D.-B. Huang, S. Malek, and G. Ghosh. 1998. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell 95: 759–770.
   PubMed Web of Science ®Google Scholar
• Iimuro Y., T. Nishiura, C. Hellerbrand, K. E. Behrns, R. Schoonhoven, J. W. Grisham, and D. A. Brenner. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101: 802–811.
   PubMedGoogle Scholar
• Kim, D. W., M. A. Sovak, G. Zanieski, G. Nonet, R. Romieu-Mourez, A. W. Lau, L. J. Hafer, P. Yaswen, M. Stampfer, A. E. Rogers, J. Russo, and G. E. Sonenshein. 2000. Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21: 871–879.
   PubMed Web of Science ®Google Scholar
• Kyprianou, N., H. F. English, N. E. Davidson, and J. T. Isaacs. 1991. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51: 162–166.
   PubMed Web of Science ®Google Scholar
• Malek, S., T. Huxford, and S. Ghosh. 1996. IκBα functions through direct contacts with the nuclear localization signals and DNA binding sequences of NF-κB. J. Biol. Chem. 273: 25427–25435.
   Google Scholar
• May, M. J., and S. Ghosh. 1997. Rel/NF-κB proteins: an overview. Semin. Cancer Biol. 8: 63–73.
   PubMed Web of Science ®Google Scholar
• Mayo, M. W., and A. S. Baldwin. 2000. The transcription factor NF-kappa B: control of oncogenesis and cancer chemotherapy resistance. Biochem. Biophys. Acta 1470: M55–M62.
   PubMedGoogle Scholar
• McGuire, W. L., G. C. Chamness, and S. A. W. Fuqua. 1991. Estrogen receptor variants in clinical breast cancer. Mol. Endocrinol. 5: 1571–1577.
   PubMed Web of Science ®Google Scholar
• Murphy, L. C., and H. Dotzlaw. 1989. Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol. Endocrinol. 3: 687–693.
   PubMedGoogle Scholar
• Na, S.-Y., J.-E. Choi, H.-J. Kim, B. H. Jhun, Y.-C. Lee, and J. W. Lee. 1999. Bcl-3, an IκB protein, stimulates activating protein-1 transactivation and cellular proliferation. J. Biol. Chem. 274: 28491–28496.
   PubMedGoogle Scholar
• Nakshatri, H., P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet, and G. W. Sledge. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17: 3629–3639.
   PubMed Web of Science ®Google Scholar
• Nechushtan, A., C. L. Smith, Y.-T. Hsu, and R. J. Youle. 1999. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 18: 2330–2341.
   PubMed Web of Science ®Google Scholar
• Nemoto, S., J. A. Di Donato, and A. Lin. 1998. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase-1 and NF-κB-inducing kinase. Mol. Cell. Biol. 18: 7336–7343.
   PubMedGoogle Scholar
• O'Connor, P. M., J. Jackman, I. Bae, T. G. Myers, S. Fan, M. Mutoh, D. A. Scudiero, A. Monks, E. A. Sausville, J. N. Weinstein, S. Friend, A. J. Fornace, and K. W. Kohn. 1997. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute Anticancer Drug Screen and correlation with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 57: 4285–4300.
   PubMed Web of Science ®Google Scholar
• Ohno, H., G. Takimoto, and T. W. McKeithan. 1990. The candidate protooncogene Bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60: 991–999.
   PubMed Web of Science ®Google Scholar
• Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86: 2336–2340.
   Google Scholar
• Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853–6866.
   PubMed Web of Science ®Google Scholar
• Perillo, B., A. Sasso, C. Abbondanza, and G. Palumbo. 2000. 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements in the coding sequence. Mol. Cell. Biol. 20: 2890–2901.
   PubMed Web of Science ®Google Scholar
• Pratt, M. A. C., S. Krajewski, M. Menard, M. Krajewska, H. Macleod, and J. C. Reed. 1998. Estrogen withdrawal-induced human breast cancer tumour regression in nude mice is prevented by Bcl-2. FEBS Lett. 440: 403–408.
   PubMedGoogle Scholar
• Price, J. E., A. Polyzos, R. D. Zhang, and L. M. Daniels. 1990. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50: 717–721.
   PubMed Web of Science ®Google Scholar
• Rayet, B., and C. Gelinas. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938–6947.
   PubMed Web of Science ®Google Scholar
• Rebollo, A., L. Dumoutier, J.-C. Renauld, A. Zaballos, V. Ayllón, and C. Martínez-A. 2000. Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors. Mol. Cell. Biol. 20: 3407–3416.
   PubMedGoogle Scholar
• Santen, R., A. Manni, H. Harvey, and C. Redmond. 1990. Endocrine treatment of breast cancer in women. Endocrine Rev. 11: 221–265.
   PubMed Web of Science ®Google Scholar
• Sommers, C. L., S. W. Byers, E. W. Thompson, J. A. Torri, and E. P. Gelmann. 1994. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res. Treat. 31: 325–335.
   Google Scholar
• Sovak, M. A., R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A. M. Traish, and G. E. Sonenshein. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Investig. 100: 2952–2960.
   PubMed Web of Science ®Google Scholar
• Tamatani, M., Y. H. Che, H. Matsuzaki, S. Ogawa, H. Okado, S. Miyake, T. Mizuno, and M. Tohyama. 1999. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274: 8531–8538.
   PubMed Web of Science ®Google Scholar
• Teixeira, C., J. C. Reed, and M. A. C. Pratt. 1995. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 protooncogene expression in human breast cancer cells. Cancer Res. 55: 3902–3907.
   PubMed Web of Science ®Google Scholar
• Valentine, J. E., E. Kalkhoven, R. White, S. Hoare, and M. G. Parker. 2000. Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J. Biol. Chem. 275: 25322–25329.
   PubMedGoogle Scholar
• Wang, C.-Y., J. C. Cusack, R. Liu, and A. S. Baldwin. 1999. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med. 5: 412–417.
   PubMedGoogle Scholar
• Westerheide, S. D., M. W. Mayo, V. Anest, J. L. Hanson, and A. S. Baldwin, Jr. 2001. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition. Mol. Cell. Biol. 21: 8428–8436.
   PubMed Web of Science ®Google Scholar
• Yoza, B. K., J. Y. Q. Hu, and C. E. McCall. 1996. Protein tyrosine-kinase activation is required for lipopolysaccharide induction of interleukin 1β and NF-κB activation, but not NF-κB nuclear translocation. J. Biol. Chem. 271: 18306–18309.
   PubMed Web of Science ®Google Scholar
• Zhou, P. B., M. C.-T. Hu, S. A. Miller, Z. Yu, W. Xia, S.-Y. Lin, and M.-C. Hung. 2000. Her-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway. J. Biol. Chem. 275: 8027–8031.
   PubMedGoogle Scholar